Prednicarbate

TargetMol
Product Code: TAR-T21443
Supplier: TargetMol
CodeSizePrice
TAR-T21443-1mg1mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21443-5mg5mg£141.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21443-10mg10mg£173.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21443-25mg25mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21443-50mg50mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21443-100mg100mg£439.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Prednicarbate is a Corticosteroid Hormone Receptor Agonist. Prednicarbate has antipruritic, anti-inflammatory, and vasoconstrictive properties. It also decreases the number of circulating lymphocytes by inhibiting the production of vasodilators such as nitric oxide and prostacyclin.
CAS:
73771-04-7
Formula:
C27H36O8
Molecular Weight:
488.577
Purity:
0.98
SMILES:
CCOC(=O)OC1(CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C)C(=O)COC(=O)CC

References

1. Otero-Rivas MM, Ruiz-Gonz?lez I, P?rez-Bustillo A, Rodr?guez-Prieto M?. Allergic contact dermatitis caused by prednicarbate presenting as chronic hand eczema. Contact Dermatitis. 2015 Jul;73(1):51-2. doi: 10.1111/cod.12374. Epub 2015 Apr 13. PubMed PMID: 25864447. 2. B?tz FM, Klipper W, Korting HC, Henkler F, Landsiedel R, Luch A, von Fritschen U, Weindl G, Sch?fer-Korting M. Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate. Eur J Pharm Biopharm. 2013 Jun;84(2):374-85. doi: 10.1016/j.ejpb.2012.11.008. Epub 2012 Nov 29. PubMed PMID: 23201050. 3. Katzer K, Tietze J, Klein E, Heinemann V, Ruzicka T, Wollenberg A. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients. Eur J Dermatol. 2010 Jan-Feb;20(1):82-4. doi: 10.1684/ejd.2010.0806. Epub 2009 Oct 2. PubMed PMID: 19797039. 4. Baspinar Y, Keck CM, Borchert HH. Development of a positively charged prednicarbate nanoemulsion. Int J Pharm. 2010 Jan 4;383(1-2):201-8. doi: 10.1016/j.ijpharm.2009.09.002. Epub 2009 Sep 10. PubMed PMID: 19747968.